would be a helpful resource. Like Bernie and I, Ping is interested in advancing clinical trials that incorporate rigorous designs typical of R&D in the Biomedical Technology and Pharmaceutical worlds. If you are inviting out-of-town speakers, there are several colleagues and friends I could recommend. Cheers, Mark Cc: iMABS Board On T